Cansino Biologics Inc. (6185)
Hong Kong Stock Exchange · Hong Kong · prices in HKD · close of 21 Oct 2026
Key indicators
| Last close | HKD 30.10 |
|---|---|
| 52-week range | 19.22 – 47.80 |
| Return, 1 month / 3 months | +14.2% / +23.7% |
| Return, 1 year / 3 years | −36.0% / +29.7% |
| Trend | Uptrend |
| RSI (14) | 47 |
| Volatility (1 year) | 66.7% |
| Worst drawdown (1 year) | -55.6% |
| Average daily value traded | 197.54M HKD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
CanSino Biologics is a biopharmaceutical company based in Tianjin, China, that researches, develops and manufactures vaccines. Its work covers preventive vaccines for infectious diseases, including meningococcal conjugate vaccines, an Ebola vaccine and a viral vector vaccine against the coronavirus. The company serves public health programmes and markets in China and other countries, and it also provides contract research and manufacturing services for other pharmaceutical companies.
Cansino Biologics Inc. trades under the code 6185 on the Hong Kong Stock Exchange in Hong Kong, with its price quoted in Hong Kong dollars (HKD). Our dividend records, which start in 2019, show payments in one calendar year. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Cansino Biologics Inc. (6185) trades on the Hong Kong Stock Exchange in Hong Kong. It last closed at HKD 30.10 on 21 October 2026.
Its price-based Market X-Ray is 59 out of 100 (a fair price profile), ranking 902 of 2,611 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 36.0% and over the last three months it rose 23.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Hong Kong Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 65 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 0.5% | ||
| From 52-week high | -36.2% | ||
| Momentum | 54 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 23.7% | ||
| 6-month return | -13.0% | ||
| 12-month return, skipping the last month | -43.9% | ||
| Stability (higher is calmer) | 38 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 66.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -55.6% | ||
| Liquidity | 94 · Strong | Trades actively. | |
| Average daily value traded | 197.54M HKD | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 1 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −4.5% |
|---|---|
| 1 month | +14.2% |
| 3 months | +23.7% |
| 6 months | −13.0% |
| 1 year | −36.0% |
| 3 years | +29.7% |
| 5 years | – |
Signals
| 50-day / 200-day average | 29.81 / 29.94 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 2.71 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 13 Jul 2022 | HKD 0.9373 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Hong Kong Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.